Literature DB >> 25973248

Symptomatic malignant pericardial effusion due to advanced pericardial malignancies: a palliative approach.

Nauman Khalid1, Lovely Chhabra1, Sarah Aftab Ahmad1, David H Spodick1.   

Abstract

Entities:  

Year:  2015        PMID： 25973248      PMCID： PMC4419300          DOI： 10.3978/j.issn.2072-1439.2015.04.05

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  6 in total

1.  Primary pericardial mesothelioma in an asbestos-exposed patient with previous heart surgery.

Authors:  Clara Rizzardi; Elena Barresi; Alessandro Brollo; Paolo Cassetti; Manuela Schneider; Mauro Melato
Journal:  Anticancer Res       Date:  2010-04       Impact factor: 2.480

2.  Malignant pericardial effusion: Different therapeutic perspectives.

Authors:  Nauman Khalid; Lovely Chhabra; David H Spodick
Journal:  J Thorac Cardiovasc Surg       Date:  2015-05       Impact factor: 5.209

3.  Primary malignant pericardial mesothelioma-a rare cause of superior vena cava thrombosis and constrictive pericarditis.

Authors:  Wenhui Gong; Xiaofeng Ye; Kaihu Shi; Qiang Zhao
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

4.  Percutaneous balloon pericardiotomy as the initial and definitive treatment for malignant pericardial effusion.

Authors:  Juan Ruiz-García; Santiago Jiménez-Valero; Raúl Moreno; Guillermo Galeote; Ángel Sánchez-Recalde; Luis Calvo; Mar Moreno-Yangüela; Sebastián Carrizo; Sergio García-Blas; José Luis López-Sendón
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2012-12-23

5.  Systemic chemotherapy in combination with pericardial window has better outcomes in malignant pericardial effusions.

Authors:  Sezai Çelik; Chiara Lestuzzi; Eugenio Cervesato; Didier Dequanter; Patrizia Piotti; Marzia De Biasio; Massimo Imazio
Journal:  J Thorac Cardiovasc Surg       Date:  2014-04-18       Impact factor: 5.209

Review 6.  Palliative treatment for symptomatic malignant pericardial effusion†.

Authors:  Guled M Jama; Marco Scarci; Jack Bowden; Stefan J Marciniak
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-08-20
  6 in total
  2 in total

1.  Important Treatment Modalities for Symptomatic Malignant Pericardial Effusions.

Authors:  Affan Umer; Nauman Khalid; Lovely Chhabra; David H Spodick
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

2.  Extenuating symptoms is very important for malignant pericardial effusion.

Authors:  Wenhui Gong; Qiang Zhao
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.